The 2018 Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS in HIV-Infected Koreans

被引：10

作者：

Kim, Nam Joong ^{[1
]}

Bang, Ji Hwan ^{[2
]}

Choi, Jun Yong ^{[3
]}

Song, Jun Young ^{[4
]}

Shin, So Yoon ^{[5
]}

Kim, Gayeon ^{[6
]}

Kim, Yeonjae ^{[6
]}

机构：

[1] Seoul Natl Univ Hosp, Div Infect Dis, Seoul, South Korea

[2] Seoul Natl Univ, Div Infect Dis, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea

[3] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea

[4] Korea Univ, Div Infect Dis, Coll Med, Seoul, South Korea

[5] Catholic Kwandong Univ, Div Infect Dis, Coll Med, Incheon, South Korea

[6] Natl Med Ctr, Ctr Infect Dis, Seoul, South Korea

来源：

INFECTION AND CHEMOTHERAPY | 2019年 / 51卷 / 01期

关键词：

Human immunodeficiency virus; Diagnosis; Anti-retroviral agents; Guideline; ACTIVE ANTIRETROVIRAL THERAPY; HUMAN-IMMUNODEFICIENCY-VIRUS; TENOFOVIR DISOPROXIL FUMARATE; REGIMEN ELVITEGRAVIR/COBICISTAT/EMTRICITABINE/TENOFOVIR DF; TREATMENT-NAIVE PATIENTS; PRIMARY-CARE GUIDELINES; ONCE-DAILY DOLUTEGRAVIR; TO-CHILD TRANSMISSION; HEPATITIS-B-VIRUS; DOUBLE-BLIND;

D O I：

10.3947/ic.2019.51.1.77

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Since the establishment of the Committee for Clinical Guidelines for the Diagnosis and Treatment of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) by the Korean Society for AIDS in 2010, clinical guidelines have been prepared in 2011, 2013, and 2015. As new research findings on the epidemiology, diagnosis, and treatment of AIDS have been published in and outside of Korea along with the development and introduction of new antiretroviral medications, a need has arisen to revise the clinical guidelines by analyzing such new data. The clinical guidelines address the initial evaluation of patients diagnosed with HIV/AIDS, follow-up tests, appropriate timing of medication, appropriate antiretroviral medications, treatment strategies for patients who have concurrent infections with hepatitis B or C virus, and treatment in pregnant women. Through these clinical guidelines, the Korean Society for AIDS and the Committee for Clinical Guidelines for the Diagnosis and Treatment of HIV/AIDS would like to contribute to overcoming AIDS by delivering the latest data and treatment strategies to healthcare professionals who treat AIDS in the clinic.

引用

页码：77 / 88

页数：12

共 73 条

[21] Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis [J].

Ford, Nathan ;

Calmy, Alexandra ;

Mofenson, Lynne .

AIDS, 2011, 25 (18) :2301-2304

[22]

FREEDBERG KA, 1994, J ACQ IMMUN DEF SYND, V7, P1134

[23] Myelomeningocele in a child with intrauterine exposure to efavirenz [J].

Fundarò, C ;

Genovese, O ;

Rendeli, C ;

Tamburrini, E ;

Salvaggio, E .

AIDS, 2002, 16 (02) :299-300

[24] Response to hepatitis B vaccine in HIV-1-positive subjects who test positive for isolated antibody to hepatitis B core antigen: Implications for hepatitis B vaccine strategies [J].

Gandhi, RT ;

Wurcel, A ;

Lee, H ;

McGovern, B ;

Shopis, J ;

Geary, M ;

Sivamurthy, R ;

Sax, PE ;

Ukomadu, C .

JOURNAL OF INFECTIOUS DISEASES, 2005, 191 (09) :1435-1441

[25] Treatment for adult HIV infection - 2006 recommendations of the International AIDS Society-USA panel [J].

Hammer, Scott M. ;

Saag, Michael S. ;

Schechter, Mauro ;

Montaner, Julio S. G. ;

Schooley, Robert T. ;

Jacobsen, Donna M. ;

Thompson, Melanie A. ;

Carpenter, Charles C. J. ;

Fischl, Margaret A. ;

Gazzard, Brian G. ;

Gatell, Jose M. ;

Hirsch, Martin S. ;

Katzenstein, David A. ;

Richman, Douglas D. ;

Vella, Stefano ;

Yeni, Patrick G. ;

Volberding, Paul A. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 296 (07) :827-843

[26] Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy [J].

Hogg, RS ;

Yip, B ;

Chan, KJ ;

Wood, E ;

Craib, KJP ;

O'Shaughnessy, MV ;

Montaner, JSG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (20) :2568-2577

[27] Monitoring plasma HIV-1 RNA levels in addition to CD4(+) lymphocyte count improves assessment of antiretroviral therapeutic response [J].

Hughes, MD ;

Johnson, VA ;

Hirsch, MS ;

Bremer, JW ;

Elbeik, T ;

Erice, A ;

Kuritzkes, DR ;

Scott, WA ;

Spector, SA ;

Basgoz, N ;

Fischl, MA ;

DAquila, RT .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :929-938

[28]

김서린, 2007, [The Korean Journal of Medicine, 대한내과학회지], V73, P243

[29] Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes [J].

Ledergerber, B ;

Lundgren, JD ;

Walker, AS ;

Sabin, C ;

Justice, A ;

Reiss, P ;

Mussini, C ;

Wit, F ;

Monforte, AD ;

Weber, R ;

Fusco, G ;

Staszewski, S ;

Law, M ;

Hogg, R ;

Lampe, F ;

Gill, MJ ;

Castelli, F ;

Phillips, AN ;

Castelli, F ;

Fusco, GP ;

Gill, MJ ;

Hogg, R ;

Lampe, F ;

Law, M ;

Ledergerber, B ;

Lundgren, JD ;

Monforte, AD ;

Mussini, C ;

Phillips, AN ;

Reiss, P ;

Staszewski, S ;

Walker, AS ;

Rooney, P ;

Taylor, S ;

Couldwell, D ;

Austin, D ;

Block, M ;

Clemons, J ;

Finlayson, R ;

Law, M ;

Petoumenos, K ;

Quan, D ;

Smith, D ;

O'Connor, C ;

Gorton, C ;

Allen, D ;

Mulhall, B ;

Mutimer, K ;

Smith, D ;

Keeffe, N .

LANCET, 2004, 364 (9428) :51-62

[30] AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy - The Swiss HIV Cohort Study [J].

Ledergerber, B ;

Erard, V ;

Weber, R ;

Hirschel, B ;

Furrer, H ;

Battegay, M ;

Vernazza, P ;

Bernasconi, E ;

Opravil, M ;

Kaufmann, D ;

Sudre, P ;

Francioli, P ;

Telenti, A .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (23) :2220-2226

← 1 2 3 4 5 6 7 8 →